| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis
|
Gou, Xiaoyun
|
|
2019
|
53 |
3 |
p. 195-206
|
article
|
| 2 |
Better Access – Necessary but not sufficient
|
Judd, Fiona
|
|
2019
|
53 |
3 |
p. 256-257
|
article
|
| 3 |
Childhood amnesia and post-traumatic stress disorder: Attachment vs default mode and executive function
|
Levy, Florence
|
|
2019
|
53 |
3 |
p. 193-194
|
article
|
| 4 |
Cognitive and educational outcomes of maltreated and non-maltreated youth: A birth cohort study
|
Mills, Ryan
|
|
2019
|
53 |
3 |
p. 248-255
|
article
|
| 5 |
Commentary on Jorm (2018) – Australia’s ‘Better Access’ scheme: Has it had an impact on population mental health?
|
Mihalopoulos, Cathrine
|
|
2019
|
53 |
3 |
p. 258-259
|
article
|
| 6 |
Community treatment orders increase community care and delay readmission while in force: Results from a large population-based study
|
Harris, Anthony
|
|
2019
|
53 |
3 |
p. 228-235
|
article
|
| 7 |
Cross-cultural differences in recovery from schizophrenia: What to compare?
|
Tirupati, Srinivasan
|
|
2019
|
53 |
3 |
p. 263
|
article
|
| 8 |
Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?
|
Inserra, Antonio
|
|
2019
|
53 |
3 |
p. 190-192
|
article
|
| 9 |
Do schizotypy dimensions reflect the symptoms of schizophrenia?
|
Thomas, Elizabeth HX
|
|
2019
|
53 |
3 |
p. 236-247
|
article
|
| 10 |
Endogenous cannabinoids and suicide
|
Sher, Leo
|
|
2019
|
53 |
3 |
p. 263-264
|
article
|
| 11 |
Impact of Australia’s ‘Better Access’ scheme on population mental health: Response to commentaries
|
Jorm, Anthony F
|
|
2019
|
53 |
3 |
p. 184-186
|
article
|
| 12 |
It’s “High Time”‽
|
Malhi, Gin S
|
|
2019
|
53 |
3 |
p. 266-267
|
article
|
| 13 |
Paracetamol, pregnancy and public health
|
Galletly, Cherrie
|
|
2019
|
53 |
3 |
p. 181-183
|
article
|
| 14 |
Reduced cortical thickness in subjects at clinical high risk for psychosis and clinical attributes
|
Kwak, Yoo Bin
|
|
2019
|
53 |
3 |
p. 219-227
|
article
|
| 15 |
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
|
Makiol, Christian
|
|
2019
|
53 |
3 |
p. 262
|
article
|
| 16 |
Thanks to Reviewers
|
|
|
2019
|
53 |
3 |
p. 268-270
|
article
|
| 17 |
The importance of assessing ‘Better Access’ appropriately: Asking the right question is an essential first step
|
Carey, Timothy A
|
|
2019
|
53 |
3 |
p. 264-265
|
article
|
| 18 |
The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive–compulsive disorder: A combined fMRI and 1H-MRS study
|
Chen, Yongjun
|
|
2019
|
53 |
3 |
p. 207-218
|
article
|
| 19 |
Treatment-resistant depressive disorders: The when, how and what of augmentation therapy
|
Bassett, Darryl
|
|
2019
|
53 |
3 |
p. 187-189
|
article
|
| 20 |
We have increased access to mental health treatment, but it needs to be effective treatment
|
Whiteford, Harvey
|
|
2019
|
53 |
3 |
p. 257-258
|
article
|
| 21 |
Where Australia’s Better Access scheme has had an impact on mental health: A commentary on Jorm (2018)
|
Lee, Christopher W
|
|
2019
|
53 |
3 |
p. 259-261
|
article
|
Journal description